Loading…

Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors

Previously synthesized novel chalcone oxime ethers (COEs) were evaluated for inhibitory activities against monoamine oxidases (MAOs) and acetylcholinesterase (AChE). Twenty-two of the 24 COEs synthesized, except and , had potent and/or significant selective inhibitory effects on MAO-B. potently inhi...

Full description

Saved in:
Bibliographic Details
Published in:Molecules (Basel, Switzerland) Switzerland), 2020-05, Vol.25 (10), p.2356
Main Authors: Oh, Jong Min, Rangarajan, T M, Chaudhary, Reeta, Singh, Rishi Pal, Singh, Manjula, Singh, Raj Pal, Tondo, Anna Rita, Gambacorta, Nicola, Nicolotti, Orazio, Mathew, Bijo, Kim, Hoon
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c493t-11872218bfdc384a51a4f395344d5b714c462b4ff8e3e1cf86dbcd73caaa6e3f3
cites cdi_FETCH-LOGICAL-c493t-11872218bfdc384a51a4f395344d5b714c462b4ff8e3e1cf86dbcd73caaa6e3f3
container_end_page
container_issue 10
container_start_page 2356
container_title Molecules (Basel, Switzerland)
container_volume 25
creator Oh, Jong Min
Rangarajan, T M
Chaudhary, Reeta
Singh, Rishi Pal
Singh, Manjula
Singh, Raj Pal
Tondo, Anna Rita
Gambacorta, Nicola
Nicolotti, Orazio
Mathew, Bijo
Kim, Hoon
description Previously synthesized novel chalcone oxime ethers (COEs) were evaluated for inhibitory activities against monoamine oxidases (MAOs) and acetylcholinesterase (AChE). Twenty-two of the 24 COEs synthesized, except and , had potent and/or significant selective inhibitory effects on MAO-B. potently inhibited MAO-B with an IC value of 0.018 µM, which was 105, 2.3, and 1.1 times more potent than clorgyline, lazabemide, and pargyline (reference drugs), respectively. , and were also active against MAO-B, both had an IC value of 0.028 µM, which was 67 and 1.5 times lower than those of clorgyline and lazabemide, respectively. Most of the COEs exhibited weak inhibitory effects on MAO-A and AChE. most potently inhibited MAO-A (IC = 0.88 µM) and also significantly inhibited MAO-B (IC = 0.13 µM), and it could be considered as a potential nonselective MAO inhibitor. and inhibited AChE with IC values of 5.35 and 4.39 µM, respectively. The selectivity index (SI) of for MAO-B was higher than that of (SI = 778.6 vs. 222.2), but the IC value (0.028 µM) was slightly lower than that of (0.018 µM). In reversibility experiments, inhibitions of MAO-B by and were recovered to the levels of reference reversible inhibitors and both competitively inhibited MAO-B, with K values of 0.0075 and 0.010 µM, respectively. Our results show that and are potent, selective MAO-B inhibitors, and is a candidate of dual-targeting molecule for MAO-B and AChE.
doi_str_mv 10.3390/molecules25102356
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_02f5c463ce624bc49f0650d4f2cab26d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_02f5c463ce624bc49f0650d4f2cab26d</doaj_id><sourcerecordid>2405930406</sourcerecordid><originalsourceid>FETCH-LOGICAL-c493t-11872218bfdc384a51a4f395344d5b714c462b4ff8e3e1cf86dbcd73caaa6e3f3</originalsourceid><addsrcrecordid>eNplkk1v1DAQhiNERUvhB3BBlrhwCfX3JheksiqwUml7gLM1scdNVk5c7KSi_x4vW6oWTrY87zzz4beq3jD6QYiWnowxoF0CZq4Y5ULpZ9URk5zWgsr2-aP7YfUy5y2lnEmmXlSHgksptOJHlb-ItxjIOkDOJHqy7iHYOCG5_DWMSM7mHlMmkMlVnHGaybc4RRiHvcBBxvoTgcmRU4vzXbB9DCWWZ0wlRDZTP3TDHFN-VR14CBlf35_H1Y_PZ9_XX-vzyy-b9el5bWUr5pqxZsU5azrvrGgkKAbSi1YJKZ3qVkxaqXknvW9QILO-0a6zbiUsAGgUXhxXmz3XRdiamzSMkO5MhMH8eYjp2kCaBxvQUO5VwQmLmsuu1PdUK-qk5xY6rl1hfdyzbpZuRGfL-AnCE-jTyDT05jremhVvGsp1Aby_B6T4cylbMeOQLYYAE8YlGy6pFqWoaor03T_SbVzSVFa1U6m2fCLdAdleZVPMOaF_aIZRs3OE-c8RJeft4ykeMv5aQPwGPnO1Mw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2405930406</pqid></control><display><type>article</type><title>Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central</source><creator>Oh, Jong Min ; Rangarajan, T M ; Chaudhary, Reeta ; Singh, Rishi Pal ; Singh, Manjula ; Singh, Raj Pal ; Tondo, Anna Rita ; Gambacorta, Nicola ; Nicolotti, Orazio ; Mathew, Bijo ; Kim, Hoon</creator><creatorcontrib>Oh, Jong Min ; Rangarajan, T M ; Chaudhary, Reeta ; Singh, Rishi Pal ; Singh, Manjula ; Singh, Raj Pal ; Tondo, Anna Rita ; Gambacorta, Nicola ; Nicolotti, Orazio ; Mathew, Bijo ; Kim, Hoon</creatorcontrib><description>Previously synthesized novel chalcone oxime ethers (COEs) were evaluated for inhibitory activities against monoamine oxidases (MAOs) and acetylcholinesterase (AChE). Twenty-two of the 24 COEs synthesized, except and , had potent and/or significant selective inhibitory effects on MAO-B. potently inhibited MAO-B with an IC value of 0.018 µM, which was 105, 2.3, and 1.1 times more potent than clorgyline, lazabemide, and pargyline (reference drugs), respectively. , and were also active against MAO-B, both had an IC value of 0.028 µM, which was 67 and 1.5 times lower than those of clorgyline and lazabemide, respectively. Most of the COEs exhibited weak inhibitory effects on MAO-A and AChE. most potently inhibited MAO-A (IC = 0.88 µM) and also significantly inhibited MAO-B (IC = 0.13 µM), and it could be considered as a potential nonselective MAO inhibitor. and inhibited AChE with IC values of 5.35 and 4.39 µM, respectively. The selectivity index (SI) of for MAO-B was higher than that of (SI = 778.6 vs. 222.2), but the IC value (0.028 µM) was slightly lower than that of (0.018 µM). In reversibility experiments, inhibitions of MAO-B by and were recovered to the levels of reference reversible inhibitors and both competitively inhibited MAO-B, with K values of 0.0075 and 0.010 µM, respectively. Our results show that and are potent, selective MAO-B inhibitors, and is a candidate of dual-targeting molecule for MAO-B and AChE.</description><identifier>ISSN: 1420-3049</identifier><identifier>EISSN: 1420-3049</identifier><identifier>DOI: 10.3390/molecules25102356</identifier><identifier>PMID: 32443652</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Acetylcholinesterase ; Acetylcholinesterase - chemistry ; Acetylcholinesterase - drug effects ; Amine oxidase (flavin-containing) ; Chalcone - chemistry ; Chalcone - pharmacology ; chalcones ; Cholinesterase Inhibitors - chemistry ; Cholinesterase Inhibitors - isolation &amp; purification ; Cholinesterase Inhibitors - pharmacology ; Drugs ; Ethers ; Ethers - chemistry ; Ethers - pharmacology ; Humans ; Inhibitors ; Kinetics ; monoamine oxidase ; Monoamine Oxidase - chemistry ; Monoamine Oxidase - drug effects ; Monoamine Oxidase Inhibitors - chemistry ; Monoamine Oxidase Inhibitors - isolation &amp; purification ; Monoamine Oxidase Inhibitors - pharmacology ; oximes ; Oximes - chemistry ; Oximes - pharmacology ; Pargyline ; reversibility ; Selectivity</subject><ispartof>Molecules (Basel, Switzerland), 2020-05, Vol.25 (10), p.2356</ispartof><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c493t-11872218bfdc384a51a4f395344d5b714c462b4ff8e3e1cf86dbcd73caaa6e3f3</citedby><cites>FETCH-LOGICAL-c493t-11872218bfdc384a51a4f395344d5b714c462b4ff8e3e1cf86dbcd73caaa6e3f3</cites><orcidid>0000-0002-5972-1879 ; 0000-0002-7203-3712</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2405930406/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2405930406?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32443652$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oh, Jong Min</creatorcontrib><creatorcontrib>Rangarajan, T M</creatorcontrib><creatorcontrib>Chaudhary, Reeta</creatorcontrib><creatorcontrib>Singh, Rishi Pal</creatorcontrib><creatorcontrib>Singh, Manjula</creatorcontrib><creatorcontrib>Singh, Raj Pal</creatorcontrib><creatorcontrib>Tondo, Anna Rita</creatorcontrib><creatorcontrib>Gambacorta, Nicola</creatorcontrib><creatorcontrib>Nicolotti, Orazio</creatorcontrib><creatorcontrib>Mathew, Bijo</creatorcontrib><creatorcontrib>Kim, Hoon</creatorcontrib><title>Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors</title><title>Molecules (Basel, Switzerland)</title><addtitle>Molecules</addtitle><description>Previously synthesized novel chalcone oxime ethers (COEs) were evaluated for inhibitory activities against monoamine oxidases (MAOs) and acetylcholinesterase (AChE). Twenty-two of the 24 COEs synthesized, except and , had potent and/or significant selective inhibitory effects on MAO-B. potently inhibited MAO-B with an IC value of 0.018 µM, which was 105, 2.3, and 1.1 times more potent than clorgyline, lazabemide, and pargyline (reference drugs), respectively. , and were also active against MAO-B, both had an IC value of 0.028 µM, which was 67 and 1.5 times lower than those of clorgyline and lazabemide, respectively. Most of the COEs exhibited weak inhibitory effects on MAO-A and AChE. most potently inhibited MAO-A (IC = 0.88 µM) and also significantly inhibited MAO-B (IC = 0.13 µM), and it could be considered as a potential nonselective MAO inhibitor. and inhibited AChE with IC values of 5.35 and 4.39 µM, respectively. The selectivity index (SI) of for MAO-B was higher than that of (SI = 778.6 vs. 222.2), but the IC value (0.028 µM) was slightly lower than that of (0.018 µM). In reversibility experiments, inhibitions of MAO-B by and were recovered to the levels of reference reversible inhibitors and both competitively inhibited MAO-B, with K values of 0.0075 and 0.010 µM, respectively. Our results show that and are potent, selective MAO-B inhibitors, and is a candidate of dual-targeting molecule for MAO-B and AChE.</description><subject>Acetylcholinesterase</subject><subject>Acetylcholinesterase - chemistry</subject><subject>Acetylcholinesterase - drug effects</subject><subject>Amine oxidase (flavin-containing)</subject><subject>Chalcone - chemistry</subject><subject>Chalcone - pharmacology</subject><subject>chalcones</subject><subject>Cholinesterase Inhibitors - chemistry</subject><subject>Cholinesterase Inhibitors - isolation &amp; purification</subject><subject>Cholinesterase Inhibitors - pharmacology</subject><subject>Drugs</subject><subject>Ethers</subject><subject>Ethers - chemistry</subject><subject>Ethers - pharmacology</subject><subject>Humans</subject><subject>Inhibitors</subject><subject>Kinetics</subject><subject>monoamine oxidase</subject><subject>Monoamine Oxidase - chemistry</subject><subject>Monoamine Oxidase - drug effects</subject><subject>Monoamine Oxidase Inhibitors - chemistry</subject><subject>Monoamine Oxidase Inhibitors - isolation &amp; purification</subject><subject>Monoamine Oxidase Inhibitors - pharmacology</subject><subject>oximes</subject><subject>Oximes - chemistry</subject><subject>Oximes - pharmacology</subject><subject>Pargyline</subject><subject>reversibility</subject><subject>Selectivity</subject><issn>1420-3049</issn><issn>1420-3049</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNplkk1v1DAQhiNERUvhB3BBlrhwCfX3JheksiqwUml7gLM1scdNVk5c7KSi_x4vW6oWTrY87zzz4beq3jD6QYiWnowxoF0CZq4Y5ULpZ9URk5zWgsr2-aP7YfUy5y2lnEmmXlSHgksptOJHlb-ItxjIOkDOJHqy7iHYOCG5_DWMSM7mHlMmkMlVnHGaybc4RRiHvcBBxvoTgcmRU4vzXbB9DCWWZ0wlRDZTP3TDHFN-VR14CBlf35_H1Y_PZ9_XX-vzyy-b9el5bWUr5pqxZsU5azrvrGgkKAbSi1YJKZ3qVkxaqXknvW9QILO-0a6zbiUsAGgUXhxXmz3XRdiamzSMkO5MhMH8eYjp2kCaBxvQUO5VwQmLmsuu1PdUK-qk5xY6rl1hfdyzbpZuRGfL-AnCE-jTyDT05jremhVvGsp1Aby_B6T4cylbMeOQLYYAE8YlGy6pFqWoaor03T_SbVzSVFa1U6m2fCLdAdleZVPMOaF_aIZRs3OE-c8RJeft4ykeMv5aQPwGPnO1Mw</recordid><startdate>20200518</startdate><enddate>20200518</enddate><creator>Oh, Jong Min</creator><creator>Rangarajan, T M</creator><creator>Chaudhary, Reeta</creator><creator>Singh, Rishi Pal</creator><creator>Singh, Manjula</creator><creator>Singh, Raj Pal</creator><creator>Tondo, Anna Rita</creator><creator>Gambacorta, Nicola</creator><creator>Nicolotti, Orazio</creator><creator>Mathew, Bijo</creator><creator>Kim, Hoon</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-5972-1879</orcidid><orcidid>https://orcid.org/0000-0002-7203-3712</orcidid></search><sort><creationdate>20200518</creationdate><title>Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors</title><author>Oh, Jong Min ; Rangarajan, T M ; Chaudhary, Reeta ; Singh, Rishi Pal ; Singh, Manjula ; Singh, Raj Pal ; Tondo, Anna Rita ; Gambacorta, Nicola ; Nicolotti, Orazio ; Mathew, Bijo ; Kim, Hoon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c493t-11872218bfdc384a51a4f395344d5b714c462b4ff8e3e1cf86dbcd73caaa6e3f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Acetylcholinesterase</topic><topic>Acetylcholinesterase - chemistry</topic><topic>Acetylcholinesterase - drug effects</topic><topic>Amine oxidase (flavin-containing)</topic><topic>Chalcone - chemistry</topic><topic>Chalcone - pharmacology</topic><topic>chalcones</topic><topic>Cholinesterase Inhibitors - chemistry</topic><topic>Cholinesterase Inhibitors - isolation &amp; purification</topic><topic>Cholinesterase Inhibitors - pharmacology</topic><topic>Drugs</topic><topic>Ethers</topic><topic>Ethers - chemistry</topic><topic>Ethers - pharmacology</topic><topic>Humans</topic><topic>Inhibitors</topic><topic>Kinetics</topic><topic>monoamine oxidase</topic><topic>Monoamine Oxidase - chemistry</topic><topic>Monoamine Oxidase - drug effects</topic><topic>Monoamine Oxidase Inhibitors - chemistry</topic><topic>Monoamine Oxidase Inhibitors - isolation &amp; purification</topic><topic>Monoamine Oxidase Inhibitors - pharmacology</topic><topic>oximes</topic><topic>Oximes - chemistry</topic><topic>Oximes - pharmacology</topic><topic>Pargyline</topic><topic>reversibility</topic><topic>Selectivity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oh, Jong Min</creatorcontrib><creatorcontrib>Rangarajan, T M</creatorcontrib><creatorcontrib>Chaudhary, Reeta</creatorcontrib><creatorcontrib>Singh, Rishi Pal</creatorcontrib><creatorcontrib>Singh, Manjula</creatorcontrib><creatorcontrib>Singh, Raj Pal</creatorcontrib><creatorcontrib>Tondo, Anna Rita</creatorcontrib><creatorcontrib>Gambacorta, Nicola</creatorcontrib><creatorcontrib>Nicolotti, Orazio</creatorcontrib><creatorcontrib>Mathew, Bijo</creatorcontrib><creatorcontrib>Kim, Hoon</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Molecules (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oh, Jong Min</au><au>Rangarajan, T M</au><au>Chaudhary, Reeta</au><au>Singh, Rishi Pal</au><au>Singh, Manjula</au><au>Singh, Raj Pal</au><au>Tondo, Anna Rita</au><au>Gambacorta, Nicola</au><au>Nicolotti, Orazio</au><au>Mathew, Bijo</au><au>Kim, Hoon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors</atitle><jtitle>Molecules (Basel, Switzerland)</jtitle><addtitle>Molecules</addtitle><date>2020-05-18</date><risdate>2020</risdate><volume>25</volume><issue>10</issue><spage>2356</spage><pages>2356-</pages><issn>1420-3049</issn><eissn>1420-3049</eissn><abstract>Previously synthesized novel chalcone oxime ethers (COEs) were evaluated for inhibitory activities against monoamine oxidases (MAOs) and acetylcholinesterase (AChE). Twenty-two of the 24 COEs synthesized, except and , had potent and/or significant selective inhibitory effects on MAO-B. potently inhibited MAO-B with an IC value of 0.018 µM, which was 105, 2.3, and 1.1 times more potent than clorgyline, lazabemide, and pargyline (reference drugs), respectively. , and were also active against MAO-B, both had an IC value of 0.028 µM, which was 67 and 1.5 times lower than those of clorgyline and lazabemide, respectively. Most of the COEs exhibited weak inhibitory effects on MAO-A and AChE. most potently inhibited MAO-A (IC = 0.88 µM) and also significantly inhibited MAO-B (IC = 0.13 µM), and it could be considered as a potential nonselective MAO inhibitor. and inhibited AChE with IC values of 5.35 and 4.39 µM, respectively. The selectivity index (SI) of for MAO-B was higher than that of (SI = 778.6 vs. 222.2), but the IC value (0.028 µM) was slightly lower than that of (0.018 µM). In reversibility experiments, inhibitions of MAO-B by and were recovered to the levels of reference reversible inhibitors and both competitively inhibited MAO-B, with K values of 0.0075 and 0.010 µM, respectively. Our results show that and are potent, selective MAO-B inhibitors, and is a candidate of dual-targeting molecule for MAO-B and AChE.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>32443652</pmid><doi>10.3390/molecules25102356</doi><orcidid>https://orcid.org/0000-0002-5972-1879</orcidid><orcidid>https://orcid.org/0000-0002-7203-3712</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1420-3049
ispartof Molecules (Basel, Switzerland), 2020-05, Vol.25 (10), p.2356
issn 1420-3049
1420-3049
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_02f5c463ce624bc49f0650d4f2cab26d
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central
subjects Acetylcholinesterase
Acetylcholinesterase - chemistry
Acetylcholinesterase - drug effects
Amine oxidase (flavin-containing)
Chalcone - chemistry
Chalcone - pharmacology
chalcones
Cholinesterase Inhibitors - chemistry
Cholinesterase Inhibitors - isolation & purification
Cholinesterase Inhibitors - pharmacology
Drugs
Ethers
Ethers - chemistry
Ethers - pharmacology
Humans
Inhibitors
Kinetics
monoamine oxidase
Monoamine Oxidase - chemistry
Monoamine Oxidase - drug effects
Monoamine Oxidase Inhibitors - chemistry
Monoamine Oxidase Inhibitors - isolation & purification
Monoamine Oxidase Inhibitors - pharmacology
oximes
Oximes - chemistry
Oximes - pharmacology
Pargyline
reversibility
Selectivity
title Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T14%3A32%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20Class%20of%20Chalcone%20Oxime%20Ethers%20as%20Potent%20Monoamine%20Oxidase-B%20and%20Acetylcholinesterase%20Inhibitors&rft.jtitle=Molecules%20(Basel,%20Switzerland)&rft.au=Oh,%20Jong%20Min&rft.date=2020-05-18&rft.volume=25&rft.issue=10&rft.spage=2356&rft.pages=2356-&rft.issn=1420-3049&rft.eissn=1420-3049&rft_id=info:doi/10.3390/molecules25102356&rft_dat=%3Cproquest_doaj_%3E2405930406%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c493t-11872218bfdc384a51a4f395344d5b714c462b4ff8e3e1cf86dbcd73caaa6e3f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2405930406&rft_id=info:pmid/32443652&rfr_iscdi=true